Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArecor Therape Share News (AREC)

Share Price Information for Arecor Therape (AREC)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
60.00
Ask:
65.00
Spread: 5.00 (8.333%)
Market Cap: £23.60m
AREC Live PriceLast checked at - London Stock Exchange

Intraday Arecor Therape Share Chart

Arecor Therape News

IN BRIEF: Arecor Therapeutics delays publication of 2023 results
3 May 2024

IN BRIEF: Arecor Therapeutics delays publication of 2023 results

Arecor Therapeutics PLC - West Sussex, England-based biopharmaceutical firm - Delays publication of 2023 results, which were due to be published Tuesd...

Arecor chief financial officer to leave in July after five years
23 Apr 2024

Arecor chief financial officer to leave in July after five years

(Alliance News) - Arecor Therapeutics PLC on Tuesday said its chief financial officer has resigned to pursue new opportunities.

Arecor to develop "holy grail" diabetes treatment with partner TRx
12 Mar 2024

Arecor to develop "holy grail" diabetes treatment with partner TRx

(Alliance News) - Arecor Therapeutics PLC on Tuesday announced a new partnership in the growing field of diabetes and obesity treatments.

EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV
29 Feb 2024

EARNINGS AND TRADING: East Star, Getech strike Kazakhstan JV

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Arecor subsidiary Tetris launching Ogluo in the Netherlands
29 Feb 2024

Arecor subsidiary Tetris launching Ogluo in the Netherlands

(Sharecast News) - Arecor Therapeutics updated the market on an announcement made by its subsidiary Tetris Pharma on Thursday, regarding the launch of...

Arecor Therapeutics hails Arestat as 2023 performance "strong"
1 Feb 2024

Arecor Therapeutics hails Arestat as 2023 performance "strong"

(Alliance News) - Arecor Therapeutics PLC on Thursday celebrated a "strong commercial performance" for 2023, touting the first commercial product inco...

IN BRIEF: Arecor pleased as investee Inhibrx sells therapy to Sanofi
23 Jan 2024

IN BRIEF: Arecor pleased as investee Inhibrx sells therapy to Sanofi

Arecor Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Notes announcement from Inhibrx Inc and Sanofi SA that both co...